So, the 7 months delayed TOGETHER study paper on Ιvermectin is about to be published. They're doing extra effort to get in the press ahead of publication, with surgically crafted statements. SCIENCE.
Last time I looked at the evidence, even when excluding everything and anything anyone objected to, there still seemed to be clear evidence in favor: doyourownresearch.substack.com/p/a-conflict-o…
But don't take it from me. Even notorious anti-ivm activist @gidmk has recently done his own, (highly subjective) summation, and concludes that "the jury is still out". Weird. He makes sure to pepper his piece with the usual talking points, of course. gidmk.medium.com/the-jury-is-st…
Besides the studies though, a usual objection is that the drug doesn't work, because it *can't* work. Or if it does, we have no idea how.
Well, if the evidence is there, and the mechanism and dosing questions have been resolved, why aren't the proper authorities recommending it?
Well, there's no way to sugar-coat this. The answer appears to be that it's due to a well-evidenced case of academic fraud.
Wait, wasn't fraud the reason ivm had any backing to begin with? Actually, no.
The sloppy or fraudulent studies that have been highly publicized are only a small subset of the total, and less than the baseline of fraudulent studies that we should expect in any body of research.
I've dug into the claims by this group of fraud researchers in detail, one such thread here, examining if indeed we see an anomalous pattern in the set of studies:
But what kind of fraud *against* ivermectin am I alleging?
Well, the earliest meta-analysis, which advised the health organizations that there wasn't enough evidence to approve, had been improperly modified by a sponsor, as the author confessed on video.
It gets worse. The person who most likely did the modifications to the paper, without being an acknowledged author, appears to be Professor Andrew Owen. Who also prepared the evidence for the strange WHO meta-analysis. philharper.substack.com/p/professor-ti…
Another negative meta-analysis, by Roman et al., makes comical errors, literally inverting the data for the treatment and control groups for a study, which were pointed out but ignored on the preprint. Had they got it right, the analysis would be positive. bird-group.org/letter-to-edit…
The gold-standard "Cochrane" review also appears to make an extreme effort to discard most of the data, and balkanize what's left, just so it can conclude there is "no evidence". osf.io/peqcj/
A reminder that Cochrane had accepted Tess Lawrie's offer to do a meta-analysis, with a team that had conducted over Cochrane 100 reviews already, and then declined to publish it.
Adding to the series of strange coincidences around this molecule, Nobel prize winner and discoverer of Ιvermectin, Professor Satoshi Omura, asked Merck to study it in the context of COVID-19 and was rejected.
Another study, PRINCIPLE, announced that they had halted their study of Ιvermectin, due to "supply chain issues". The supplier denied there had ever been such issues. The trial has now resumed, but we have no idea why it was halted to begin with.
What about the TOGETHER trial, discussed at the top of this thread? Well, it seems to have made several serious errors, most of which would have been disqualifying on their own, including not checking if the control group was already on the drug! doyourownresearch.substack.com/p/what-went-wr…
In the meantime, ivmmeta.com, a site with as many fans as it has haters, shows positive, consistent results that fit the proposed mechanisms of action, and are robust to exclusions. It's like 700+ researchers worldwide conspired to make it look like this.
What about safety though? Can we afford to take a risk if we're not certain? Well, it's no remdesivir, but it's pretty ok. I'm kidding, of course. @chrismartenson has reviewed an exhaustive review paper on this, concluding it's about as safe as it gets.
So, as it stands, it does seem that Ιvermectin is the most prominent and blatant demonstration of manipulation of the medical and scientific literature throughout the pandemic, to invert the obvious conclusion of the studies when summarized plainly.
And even if one believes we should have more data, we must ask the question: why didn't the NIAID perform a large scale thorough and fair trial, so it can answer the question for good? It didn't have a problem advocating for remdesivir on much less data. doyourownresearch.substack.com/p/the-remdesiv…
I suppose we'll see more studies rolling in, and the usual pattern: negative studies will get press, while positive ones, like the one from @sabinehazanmd, will be ignored.
As for me, I await a trial that is done to the same standard as other early treatment anti-viral agents, such as Molnupiravir and Paxlovid. We know what a good study design looks like, let's use it. If it fails, it fails. But let's, for once, apply even standards.
And please no more garbage studies like the recent one from Malaysia that had the patients fail the primary endpoint in 3 days, while claiming to test a 5-day treatment. Drugs don't have time machines.
While everyone has their eyes on Ukraine, there's a comprehensive control system being erected all around us.
Let's count the ways. 🧵
First, there is the treaty being worked on, on the level of the WHO. The details have not been worked out yet, but the Director General of the WHO is pushing for a binding treaty with the power to apply sanctions if 2/3rds of the members agree.
What you are seeing me do in the case of Ukraine is what I always try to: first principles thinking.
Allow me to summarize: 🧵
First of all, I don't have a position on the matter at all. It still appears too complex for me. I feel badly for the Ukrainian people suffering what they are, of course, as I feel for the Yemenis and Uighurs.
Second, the revelation on biolabs taught me to not ignore something, just because Putin said it.
Denison’s lab and its collaborators at the University of North Carolina (Baric) conducted the preclinical work showing that remdesivir could stop coronaviruses from replicating.
In Feb 2020, he was pretty clear that it should be given early.
Later in the Q&A he said about potential trials: "if we design it to just treat those who are in the ICU, on a ventilator, then we might as well not design the trial".
So Denison, in the presence of Ralf Baric, said it clearly: remdesivir should be given early or not at all. And yet we designed trials to give it late. Exactly how they knew it couldn't work. Why?
More on the Remdesivir Riddle here:
Daszak interview with the intercept, un-paywalled link: archive.ph/4Kb55
Haven't read it yet, will probably turn this into a 🧵 as I go.
Ooh! He throws Baric under the bus, ever so gently.
Remember when Daszak emailed Baric and told him "I spoke with Linfa [Wang] last night"... "we'll then put it out in a way that doesn't link it back to our collaboration"
So, what are these Ukrainian biolabs? They appear to be run by a company called Metabiota.
The linked article has a *lot* of information I'd prefer to confirm more tightly first, but time is of the essence, so decide for yourselves: armswatch.com/the-pentagon-b…
So how did they do in Sierra Leone during the Ebola outbreak? CBS says.. not well. cbsnews.com/news/american-…